- 140
- 36 562
CEU CMC Vellore
เข้าร่วมเมื่อ 28 มิ.ย. 2014
ARTIFICIAL INTELLIGENCE IN MEDICINE (PART – V) _ DR. THAMBU DAVID
CLINICAL EPIDEMIOLOGY UNIT, CMC VELLORE
ARTIFICIAL INTELLIGENCE IN MEDICINE (PART - V) _ DR. THAMBU DAVID VENUE : CEU, CMC VELLORE
ARTIFICIAL INTELLIGENCE IN MEDICINE (PART - V) _ DR. THAMBU DAVID VENUE : CEU, CMC VELLORE
มุมมอง: 7
วีดีโอ
ARTIFICIAL INTELLIGENCE IN MEDICINE (PART - IV) _ DR. THAMBU DAVID
มุมมอง 64 ชั่วโมงที่ผ่านมา
CLINICAL EPIDEMIOLOGY UNIT, CMC VELLORE ARTIFICIAL INTELLIGENCE IN MEDICINE (PART - IV) _ DR. THAMBU DAVID VENUE : CEU, CMC VELLORE
ARTIFICIAL INTELLIGENCE IN MEDICINE (PART - III) _ DR. THAMBU DAVID
มุมมอง 84 ชั่วโมงที่ผ่านมา
CLINICAL EPIDEMIOLOGY UNIT, CMC VELLORE ARTIFICIAL INTELLIGENCE IN MEDICINE (PART - III) _ DR. THAMBU DAVID VENUE : CEU, CMC VELLORE
ARTIFICIAL INTELLIGENCE IN MEDICINE (PART - II) _ DR. THAMBU DAVID
มุมมอง 147 ชั่วโมงที่ผ่านมา
CLINICAL EPIDEMIOLOGY UNIT, CMC VELLORE ARTIFICIAL INTELLIGENCE IN MEDICINE (PART - II) _ DR. THAMBU DAVID VENUE : CEU, CMC VELLORE
ARTIFICIAL INTELLIGENCE IN MEDICINE (PART - I) _ DR. THAMBU DAVID
มุมมอง 277 ชั่วโมงที่ผ่านมา
CLINICAL EPIDEMIOLOGY UNIT, CMC VELLORE ARTIFICIAL INTELLIGENCE IN MEDICINE (PART - I) _ DR. THAMBU DAVID VENUE : CEU, CMC VELLORE
CONSORT - AI CHECKLIST FOR AN RCT USING AI_ DR. JAHNAWIRAVINDRA MARATHE
มุมมอง 3114 วันที่ผ่านมา
CLINICAL EPIDEMIOLOGY UNIT, COCHRANE CMC VELLORE AFFILIATE SHORT COURSE IN EPIDEMIOLOGY - CONSORT - AI CHECKLIST FOR AN RCT USING AI APPRAISER : DR. JAHNAWI RAVINDRA MARATHE MODERATOR : DR. THAMBU DAVID DATE : Nov 02, 2024 VENUE : CEU, CMC VELLORE
AMSTAR and CheckMAP TOOLS FOR AN IPD META-ANALYSIS_ DR. JAHNAWIRAVINDRA MARATHE
มุมมอง 53หลายเดือนก่อน
CLINICAL EPIDEMIOLOGY UNIT, COCHRANE CMC VELLORE AFFILIATE SHORT COURSE IN EPIDEMIOLOGY - AMSTAR and CheckMAP TOOLS FOR AN IPD META-ANALYSIS APPRAISER : DR. JAHNAWI RAVINDRA MARATHE MODERATOR : Prof. PRATHAP THARYAN DATE : OCTOBER 26, 2024 VENUE : CEU, CMC VELLORE
PROPENSITY SCORE -A COHORT STUDY CRITICAL APPRAISAL _ DR. JAHNAWI RAVINDRA MARATHE
มุมมอง 84หลายเดือนก่อน
CLINICAL EPIDEMIOLOGY UNIT, COCHRANE CMC VELLORE AFFILIATE SHORT COURSE IN EPIDEMIOLOGY - CPROPENSITY SCORE -A COHORT STUDY CRITICAL APPRAISAL APPRAISER : DR. JAHNAWI RAVINDRA MARATHE (Consultant - General Medicine) MODERATORS : Prof. L. JEYASEELAN (Professor of Biostatistics, Mohammad Bin Rashid University, Dubai, UAE) & Ms. MALAVIKA (Centre for Trials Research, Cardiff university) DATE : OCTO...
CRITICAL APPRAISAL OF A DIAGNOSTIC PREDICTION MODEL STUDY TRIPOD & STARD- DR.SAKSHI PARSARAMPURIA
มุมมอง 53หลายเดือนก่อน
CLINICAL EPIDEMIOLOGY UNIT, COCHRANE CMC VELLORE AFFILIATE SHORT COURSE IN EPIDEMIOLOGY - CRITICAL APPRAISAL OF A DIAGNOSTIC PREDICTION MODEL STUDY TRIPOD & STARD APPRAISER : DR.SAKSHI PARSARAMPURIA MODERATOR : DR. VIGNESH KUMAR C DATE : OCTOBER 12, 2024 VENUE : CEU, CMC VELLORE
WHY AN RCT _ DR SHRIKANT BANGDIWALA
มุมมอง 34หลายเดือนก่อน
Clinical Trials Course “Design, Analyses And Interpretation” December 04-06, 2023 Organized By Clinical Epidemiology Unit & Cochrane CMC Vellore Affiliate Christian Medical College, Vellore In collaboration with the Cochrane Canada Centre and Population Health Research Institute, McMaster University, Ontario, Canada.
TYPES OF ANALYSIS _ DR SHRIKANT BANGDIWALA
มุมมอง 58หลายเดือนก่อน
Clinical Trials Course “Design, Analyses And Interpretation” December 04-06, 2023 Organized By Clinical Epidemiology Unit & Cochrane CMC Vellore Affiliate Christian Medical College, Vellore In collaboration with the Cochrane Canada Centre and Population Health Research Institute, McMaster University, Ontario, Canada.
TYPE OF HYPOTHESIS _ DR SHRIKANT BANGDIWALA
มุมมอง 47หลายเดือนก่อน
Clinical Trials Course “Design, Analyses And Interpretation” December 04-06, 2023 Organized By Clinical Epidemiology Unit & Cochrane CMC Vellore Affiliate Christian Medical College, Vellore In collaboration with the Cochrane Canada Centre and Population Health Research Institute, McMaster University, Ontario, Canada.
SYSTEMATIC REVIEW _ DR THAMBU DAVID
มุมมอง 42หลายเดือนก่อน
Clinical Trials Course “Design, Analyses And Interpretation” December 04-06, 2023 Organized By Clinical Epidemiology Unit & Cochrane CMC Vellore Affiliate Christian Medical College, Vellore In collaboration with the Cochrane Canada Centre and Population Health Research Institute, McMaster University, Ontario, Canada.
STUDY DESIGNS _ DR THAMBU DAVID
มุมมอง 104หลายเดือนก่อน
Clinical Trials Course “Design, Analyses And Interpretation” December 04-06, 2023 Organized By Clinical Epidemiology Unit & Cochrane CMC Vellore Affiliate Christian Medical College, Vellore In collaboration with the Cochrane Canada Centre and Population Health Research Institute, McMaster University, Ontario, Canada.
SECONDARY ANALYSIS OF A CLINICAL TRIAL _ DR SHRIKANT BANGDIWALA
มุมมอง 16หลายเดือนก่อน
Clinical Trials Course “Design, Analyses And Interpretation” December 04-06, 2023 Organized By Clinical Epidemiology Unit & Cochrane CMC Vellore Affiliate Christian Medical College, Vellore In collaboration with the Cochrane Canada Centre and Population Health Research Institute, McMaster University, Ontario, Canada.
PHASE I AND PHASE II DESIGNS _ DR MAHESH IYER
มุมมอง 54หลายเดือนก่อน
PHASE I AND PHASE II DESIGNS _ DR MAHESH IYER
OPERATIONAL DESIGN CONSIDERATIONS IN RCTS _ DR SHRIKANT I BANGDIWALA
มุมมอง 26หลายเดือนก่อน
OPERATIONAL DESIGN CONSIDERATIONS IN RCTS _ DR SHRIKANT I BANGDIWALA
INTERIM ANALYSIS IN A CLINICAL TRIAL _ DR SHRIKANT I BANGDIWALA
มุมมอง 32หลายเดือนก่อน
INTERIM ANALYSIS IN A CLINICAL TRIAL _ DR SHRIKANT I BANGDIWALA
DEFINING THE STUDY OUTCOME _ DR SHRIKANT I BANGDIWALA
มุมมอง 21หลายเดือนก่อน
DEFINING THE STUDY OUTCOME _ DR SHRIKANT I BANGDIWALA
CRITICAL APPRAISAL OF A RANDOMIZED CONTROL TRIAL _ DR THAMBU DAVID
มุมมอง 90หลายเดือนก่อน
CRITICAL APPRAISAL OF A RANDOMIZED CONTROL TRIAL _ DR THAMBU DAVID
CONFIDENCE INTERVALS _ DR. L. JEYASEELAN
มุมมอง 62หลายเดือนก่อน
CONFIDENCE INTERVALS _ DR. L. JEYASEELAN
CONDITION POWER IN INTERIM ANALYSES OF A CLINICAL TRIAL _ DR. L. JEYASEELAN
มุมมอง 79หลายเดือนก่อน
CONDITION POWER IN INTERIM ANALYSES OF A CLINICAL TRIAL _ DR. L. JEYASEELAN
COMMON RCT DESIGNS IN PHASE IIB AND III CLINICAL TRIALS - PART II _ DR. SHRIKANT I. BANGDIWALA
มุมมอง 47หลายเดือนก่อน
COMMON RCT DESIGNS IN PHASE IIB AND III CLINICAL TRIALS - PART II _ DR. SHRIKANT I. BANGDIWALA
COMMON RCT DESIGNS IN PHASE IIB AND III CLINICAL TRIALS - PART I _ DR. SHRIKANT I. BANGDIWALA
มุมมอง 35หลายเดือนก่อน
COMMON RCT DESIGNS IN PHASE IIB AND III CLINICAL TRIALS - PART I _ DR. SHRIKANT I. BANGDIWALA
CRITICAL APPRAISAL OF A CROSS SECTIONAL STUDY _ DR.SAKSHI PARSARAMPURIA
มุมมอง 34หลายเดือนก่อน
CRITICAL APPRAISAL OF A CROSS SECTIONAL STUDY _ DR.SAKSHI PARSARAMPURIA
CRITICAL APPRAISAL OF HEALTH INFORMATION ON SOCIAL PLATFORMS - DR.SAKSHI PARSARAMPURIA
มุมมอง 332 หลายเดือนก่อน
CRITICAL APPRAISAL OF HEALTH INFORMATION ON SOCIAL PLATFORMS - DR.SAKSHI PARSARAMPURIA
CRITICAL APPRAISAL OF A CLUSTER RANDOMIZED CONTROLLED TRIAL USING RoB2 TOOL _DR. DAVID MATHEW DANIEL
มุมมอง 252 หลายเดือนก่อน
CRITICAL APPRAISAL OF A CLUSTER RANDOMIZED CONTROLLED TRIAL USING RoB2 TOOL _DR. DAVID MATHEW DANIEL
CRITICAL APPRAISAL OF A QUALITATIVE STUDY _ DR. SAKSHI PARSARAMPURIA
มุมมอง 312 หลายเดือนก่อน
CRITICAL APPRAISAL OF A QUALITATIVE STUDY _ DR. SAKSHI PARSARAMPURIA
CRITICAL APPRAISAL OF A GUIDELINE - Dr. David Mathew Daniel
มุมมอง 972 หลายเดือนก่อน
CRITICAL APPRAISAL OF A GUIDELINE - Dr. David Mathew Daniel
CRITICAL APPRAISAL OF A RANDOMIZED CONTROLLED TRIAL WITH A WIN RATIO - Dr. David Mathew Daniel
มุมมอง 872 หลายเดือนก่อน
CRITICAL APPRAISAL OF A RANDOMIZED CONTROLLED TRIAL WITH A WIN RATIO - Dr. David Mathew Daniel
What do you think of the PACE trial as an example of what not to do? No significant benefit to objective measures but it's promoted by it's authors&supporters as evidence for recommending their cure. th-cam.com/video/PRCQ-kIxQyY/w-d-xo.htmlsi=Mf_bLDqfkU8FQzk_
Lee George Davis Timothy Anderson Susan
Thank you very much. I have three questions 1) In the R code it is shown in minute 48, what you call the cens variable is coded 0, 1, 2, and 3, isnt' it? Thus 2 and 3 events are automatically considered competing risks/events when you set failcode is 1 (default), isn't it? 2) You then use cens2, why that change? 3) Third and last question, for a cathegorical covariate with more than two categories you need to convert it into dummies variables, the crr doesn't do the job automatically, does it?
Great video Dr. Horny Was wondering if Markov models are in use currently for drug approval process ? My question is this: Is FDAs drug approval process in clinical trials system called “ golden standard” can be improved in cost and time for all stakeholders ?
Thank you for the video. It is saving me here
Hi, is it possible to get the PPT.
This is very helpful
Thanks Dr.Michal for this life-saving video.It couldn't be more timely
I am getting Data_object error while doing ROC analysis of Comparison. What is wrong in this?
Very good initiative by Prof. Jeyaseelan.
vnp33 vyn.fyi
Good informative video. visit us Yelagiri resorts, Hotels in yelagiri
Thank you sir, was a great opportunity for us to present. Elizabeth Vinod
Great programme Congrats Thambu and co.